Center for Medicinal Cannabis Research
20
3
7
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.0%
4 terminated/withdrawn out of 20 trials
69.2%
-17.3% vs industry average
5%
1 trials in Phase 3/4
33%
3 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)
Role: collaborator
A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients
Role: collaborator
Role of CBD in Improving Alexithymia
Role: collaborator
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
Role: collaborator
Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity
Role: collaborator
Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism
Role: collaborator
THC Effects on Glucose in Type 2 Diabetes
Role: collaborator
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study
Role: collaborator
The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol
Role: collaborator
Trial of Cannabis for Essential Tremor
Role: collaborator
Effects of Vaporized Marijuana on Neuropathic Pain
Role: collaborator
Marijuana for Cancer Pain
Role: lead
Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
Role: lead
Effects of Smoked Marijuana on Neuropathic Pain
Role: lead
Medicinal Cannabis for Painful HIV Neuropathy
Role: lead
Vaporization as a Smokeless Cannabis Delivery System
Role: lead
Marijuana for HIV-Related Peripheral Neuropathy
Role: lead
Cannabis for Spasticity in Multiple Sclerosis
Role: lead
Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis
Role: lead
Analgesic Efficacy of Smoked Cannabis
Role: lead
All 20 trials loaded